Oncology Services:Clinical Trials

Current Clinical Trials

BREAST, ADJUVANT

AMGEN 20110147 — Randomized Phase 2 study to estimate the effect of prophylactic intervention with naproxyn or loratadine on bone pain in breast cancer subjects receiving chemotherapy and pegfilgrastim

NSABP B47 — A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

S1007 — A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

BREAST, DCIS

NSABP B43 — A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

BREAST, METASTATIC

E2108 — A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer

E3108 — A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen

BREAST, MIBC

Z11102 — Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers (MIBC)

COLORECTAL, ADJUVANT

CALGB 80702 A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer

NSABP P5

Polyp Prevention Trial in Patients with Resected Colon Cancer

GU

CALGB 90601 — A Randomized, Double-Blinded Phase III Study Comparing Gemcit abine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

HEAD/ NECK

E1305 — A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

LEUKEMIA

Connect CLL: The CLL Registry

LUNG, NONSMALL CELL, ADJUVANT

E1505 — A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (>/= 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC)

LUNG, NONSMALL CELL, METASTATIC

CALGB 30607 — Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum–Based Combination Chemotherapy in Advanced Stage IIIB/IV Non-Small Cell Lung Cancer

E5508 — Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

MDS/ MULTIPLE MYELOMA

E2905 — Randomized Phase II Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate-1 Risk MDS and Symptomatic Anemia

MELANOMA

E2607 — A Phase II trial of Dasatinib in Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral, and Solar Melanoma

CYBERKNIFE

ReCKord Cyberknife Patient Registry
Registry for Prostate Cancer Radiosurgery

Please contact Dawn Radakovich, Research Nurse Navigator at 630-758-8640 for more details.

Elmhurst Memorial Healthcare Network

This site is part of the Elmhurst Memorial Healthcare network of Web sites, which covers a variety of topics using the same philosophy: When it comes to medical care, we know that you have a lot of options. And we want you to know that you're more than a patient to us. You're an individual. We would appreciate the opportunity to provide you with state-of-the-art medical care and down-to-earth, personalized attention.

Get our classes & events newsletter

View more Newsletters